Dr. Helena Peilot Sjögren

AstraZeneca R&D, Sweden

How to run the perfect experiment for better assay development

The Discovery Biology department at AstraZeneca develops assays to support early drug discovery all the way through to early clinical development. However, in this work, there is often a disconnect between experimental design, execution, and analysis. In this video, Dr. Helena Peilot Sjögren outlines how she uses the Synthace platform to translate complex experimental design into a set of clear instructions to run experiments in the lab and output data that can be easily formatted for further analysis. This video was filmed at SLAS Europe 2022.



LIKE 1


Dr. Helena Peilot Sjögren
Health Sciences SLAS

Dr. Helena Peilot Sjögren

Biography

Associate Principal Scientist More

Dr. Helena Peilot Sjögren

AstraZeneca R&D, Sweden

Helena Peilot Sjögren is a cell biologist with a focus on early drug discovery. She develops cell assays, screening strategies, and drives projects in early discovery and technology development. Helena has a passion for the science behind the drug discovery process and loves to see what can be translated into value for patients. In addition, she thrives in the collaborative spirit of working together in a global company with a common goal.